Lenalidomide vs Methotrexate in Difficult-to-treat Cutaneous Lupus Erythematosus

NCT06965244 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

122

Enrollment

OTHER

Sponsor class

Conditions

Cutaneous Lupus Erythematosus (CLE)

Interventions

DRUG: Lenalidomide
DRUG: Methotrexate (MTX)

Sponsor

Assistance Publique - Hôpitaux de Paris